Department of Hematology

Hematology Home >

Faculty

Tracey L. Evans, MD

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania and the Presbyterian Medical Center of Philadelphia and the Veteran's Administration Medical Center

Department: Medicine

Contact information

Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104-4283

Office: 215-662-6681
Fax: 215-615-5888

Email:
tracey.evans@uphs.upenn.edu

Education:
BA (Biology and Philosophy)
University of Delaware, Summa Cum Laude, 1992.
MD
University of Pennsylvania, 1996.

Post-Graduate Training
Intern in Medicine, Brigham & Women's Hospital, Boston, MA, 1996-1997.
Resident in Medicine, Brigham & Women's Hospital, 1997-1999.
Fellowship, Hematology-Oncology, Dana-Farber/Partners Cancer Care, Boston, MA, 1999-2002.

Certifications
American Board of Internal Medicine Diplomate in Internal Medicine, 1999.
American Board of Internal Medicine Diplomate in Oncology, 2002.
American Board of Internal Medicine Diplomate in Hematology, 2002.

Permanent link

> School of Medicine > Faculty > Details

Description of Research Expertise

Thoracic Malignancies
Lung Cancer

Description of Clinical Expertise

Thoracic Malignancies
Lung Cancer

Selected Publications

A. Berman, S. Singhal, S. Su, Kucharczuk JC, J. Cooper, J. Shrager, L. Kaiser, J. Friedberg, J. Faerber, T. Evans, J. Stevenson, C.J. Langer, J. Metz, E. Glatstein, S.M. Hahn, R. Rengan: Adjuvant Radiotherapy for Completely Resected Stage II Thymoma. International Association for the study of Lung Cancer. 13th World Conference on Lung Cancer. San Francisco, CA July 2009.

R. Rengan, R. Mick, L. Lin, A. Maity, A. Gupta, T. Evans, J. Stevenson, C.J. Langer MD, Kucharczuk JC, J. Friedberg, S. Prendergast, J. Driesbaugh, and S.M. Hahn: Early Results of a Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy (CT-RT) for Stage IIIA/IIIB NSCLC. International Association for the study of Lung Cancer. 13th World Conference on Lung Cancer. San Francisco, CA. July 2009.

Weiss J, Evans T, Eaby B, Stevenson J, Kucharczuk J, CooperJ , Kaiser L, Shrager J, Rengan R, Langer C. : Adjuvant Cisplatin and Docetaxel (CDDP-Doc) for Non small cell Lung Cancer (NSCLC): the Hospital of the University of Pennsylvania (HUP) Experience. 13th World Conference on Lung Cancer. San Francisco, CA July 2009.

A. Fernandes, J. Faerber, J. Finlay, J. Shen, L. Lin, T. Evans, J. Stevenson, C. Langer, E. Glatstein, S. Hahn, R. Rengan: Clinical outcomes of elective nodal irradiation (ENI) compared with involved field radiotherapy (IFRT) in NSCLC. American Sociey of Clinical Oncology Annual Meeting Proceedings. Steven M. Grunberg, MD (eds.). 27(15S): 392s, May 2009.

Tracey Evans: "Bevacizumab: the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer", Link http://www.hstalks.com/?t=BL0372105-Evans Cancer Therapy: Latest thinking in efficacy and toxicity, The Biomedical & Life Sciences Collection, (online at http://www.hstalks.com/?t=BL0372105-Evans) in Innocenti , F. and Liu , G. (eds.). Henry Stewart Talks Ltd, London 2009.

Tracey Evans : Novel, Targeted Agents with Thoracic Radiation in the Treatment of Locally Advanced Non-small Cell Lung Cancer. 2009 ASCO Educational Bood 2009.

Tracey Evans : Thymomas/Mediastinal Neoplasms (in press). Oncology inPractice. Corey Langer (eds.). Clinical Care Options, LLC, Atlanta, Georgia 30316 2009.

Tracey Evans, MD and Corey Langer, MD, FACP: Safety of Antiangiogenic Agents in Advanced Non-small Cell Lung Cancer: What Do We Know in 2008? Advances in Lung Cancer. Physicians Education Resource, 8(1): 7, October 2008 Notes: CME-certified.

Sequist LV, Martins RG, Spigel D, Grunberg SM, Spira A, Jänne PA, Joshi VA, McCollum D, Evans T, Muzikansky A, Kuhlman G, Goldberg JS, Patel J, Malamud S, Settleman J, Iafrate AJ, Engelman JA, Haber DA, Johnson BE, Lynch TJ: First-line gefitinib in advanced non-small-cell lung cancer patients harboring somatic EGFR mutations. Journal of Clinical Oncology. Daniel Haller (eds.). American Society of Clinical Oncology, 26(15): 2442-9, May 2008.

Nathan A. Pennell, M.D., Ph.D., Gilbert H. Daniels, M.D., Robert I. Haddad, M.D., Douglas S. Ross, M.D., Tracey Evans, M.D., Lori J. Wirth, M.D., Panos H. Fidias, M.D., Jennifer S. Temel, M.D., Sarada Gurubhagavatula, M.D., Rebecca Suk Heist, M.D., M.P.H., John R. Clark, M.D., and Thomas J. Lynch, M.D. : A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer. Thyroid 18(3): 317-23, March 2008.